News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
173 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17923)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
The overall goal of the collaboration is to leverage DZNE’s advanced research capabilities with ChemDiv’s commercial expertise to efficiently design and validate new therapeutic candidates for treatment of Alzheimer’s and other neurodegenerative diseases.
January 4, 2018
·
3 min read
Zora Announces CERT - A Validated Test for Cardiovascular and Diabetes Risk Prediction
Zora announces the expansion of its Coronary Event Risk Test to include prediction of type II diabetes.
January 4, 2018
·
4 min read
Business
Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer
Mr. Wilson joins Crinetics from Cidara Therapeutics, where he was Vice President of Finance and Accounting and Chief Accounting Officer.
January 4, 2018
·
2 min read
Drug Development
Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients
The company expects that a decision on a potential filing for approval based on Phase 2 data will be made in mid-2018.
January 4, 2018
·
7 min read
Drug Development
Asterias Biotherapeutics Reports Milestone Targets for 2018
These achievements, combined with the Company’s financial resources position Asterias to achieve the following milestones during 2018.
January 4, 2018
·
6 min read
Business
BioPorto: Changes in the Board of Directors - Jan. 4, 2018
Board member Niels Christian Nielsen will not be seeking re-election at BioPorto’s Annual General Meeting on April 13, 2018.
January 4, 2018
·
1 min read
Business
Peli BioThermal Hires Dominic Hyde as New VP of Credo on Demand
With more than 23 years engineering expertise and leadership experience, Hyde will manage the worldwide expansion of Peli BioThermal’s Credo on Demand rental program.
January 4, 2018
·
2 min read
FDA
Cerebrotech Visor Receives FDA Clearance
The clearance includes a broad indication for use as an aid in the assessment of fluid volume differences between the cerebral hemispheres in patients undergoing neurologic assessment.
January 4, 2018
·
3 min read
Business
Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer
Mr. Swirsky was most recently President, CEO and a director of GenVec.
January 4, 2018
·
4 min read
Biotech Beach
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
CURE’s proprietary CUREfilm technology platform optimizes drug delivery for better patient outcomes and experiences.
January 4, 2018
·
3 min read
Previous
17 of 18
Next